Wakamoto Pharmaceutical Co.,Ltd.TSE 4512

わかもと製薬株式会社 · Pharmaceutical · FY ends Mar

Share price at FY-end
¥351
FY ending Mar 2026
Market cap at FY-end
¥12.2B
Dividend per share
¥3.5
Avg. director pay
¥13.0M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 Rohto Pharmaceutical Co., Ltd. 3,971,000 11.44% ¥1.4B ¥13.9M
2 Kissei Pharmaceutical Co., Ltd. 3,778,000 10.89% ¥1.3B ¥13.2M
3 AVI JAPAN OPPORTUNITY TRUST PLC 2,998,000 8.64% ¥1.1B ¥10.5M
4 Brest Sieve Co., Ltd. 2,500,000 7.20% ¥876M ¥8.8M
5 わかもと製薬取引先持株会 2,012,000 5.80% ¥705M ¥7.0M
6 朝日生命保険相互会社 1,204,000 3.47% ¥422M ¥4.2M
7 日本ゼトック株式会社 1,201,000 3.46% ¥421M ¥4.2M
8 株式会社みずほ銀行 1,093,000 3.15% ¥383M ¥3.8M
9 SG/UCITS V/INV 867,000 2.50% ¥304M ¥3.0M
10 アクサ生命保険株式会社 789,000 2.28% ¥277M ¥2.8M

Officers' holdings and pay

NameTitleSharesValuePay
平井 友行 President & Representative Director 7,000 ¥2.5M —
五十嵐 新 Chairman of the Board 62,000 ¥21.7M —
佐藤 公彦 Managing Director 32,000 ¥11.2M —
葛西 洋芳 Director 23,000 ¥8.1M —
谷口 誠 Director 15,000 ¥5.3M —
平田 晴久 Director 84,000 ¥29.5M —
惠島 克芳 Director — — —
桑原 育朗 Director — — —
樋川 加奈 Director — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 ¥351 ¥6.54 53.6x ¥3.5 34,838,000
FY ending Mar 2025 ¥317 ¥1.85 171.3x ¥3.0 34,838,000
FY ending Mar 2024 ¥227 ¥3.13 72.5x ¥3.0 34,838,000
Source: annual securities reports on EDINET. Values are estimates. Methodology